Cargando…
ATF3 Demethylation Promotes the Transcription of ARL4C, Which Acts as a Tumor Suppressor in Human Breast Cancer
INTRODUCTION: Breast cancer is a common malignancy in females worldwide. In this study, we investigated the role of activating transcription factor 3 (ATF3) and ADP-ribosylation factor like-4 (ARL4) in human breast cancer, and the associated mechanisms. MATERIALS AND METHODS: We measured ATF3 and AT...
Autores principales: | Li, Liqi, Sun, Rong-Mao, Jiang, Guo-Qin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195577/ https://www.ncbi.nlm.nih.gov/pubmed/32425548 http://dx.doi.org/10.2147/OTT.S243632 |
Ejemplares similares
-
MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation
por: Zhang, Zhen, et al.
Publicado: (2019) -
Correction to “MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation”
por: Zhang, Zhen, et al.
Publicado: (2022) -
Damage‐inducible intragenic demethylation of the human TP53 tumor suppressor gene is associated with transcription from an alternative intronic promoter
por: Blackburn, James, et al.
Publicado: (2015) -
ARL3 is downregulated and acts as a prognostic biomarker in glioma
por: Wang, Yulin, et al.
Publicado: (2019) -
ARL11 correlates with the immunosuppression and poor prognosis in breast cancer: A comprehensive bioinformatics analysis of ARL family members
por: Xie, Ning, et al.
Publicado: (2022)